Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 29,475

Document Document Title
WO/2015/158426A1
The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis ...  
WO/2015/155230A1
The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates fr...  
WO/2015/156846A1
A process for preparing cyclic dehydration products from sugar alcohols is described. The process involve using a mixed-acid catalyst reaction mixture containing a reducing acid, having a pKa of about 1.0-1.5, and at least a strong Brøn...  
WO/2015/156645A1
The present invention relates to the preparation of a useful compound, which can be used as an intermediate for preparing an important compound, in the industrial field, from a homoserine-based compound, and provides a process for treati...  
WO/2015/155784A1
The present invention relates to a novel process for the preparation of 2,5-furandicarboxylic acid of formula- (1). and its ester derivative chemically denoted as dimethyl 2,5-furandicarboxylate of formula-(2). FDCA is found to be one of...  
WO/2015/154673A1
The invention relates a pharmaceutical composition comprising (i) prodrugs of NEP inhibitors, (ii) mutual prodrugs of angiotensin receptor antagonist and a NEP inhibitor, (iii) a combination of an angiotensin receptor antagonist prodrug ...  
WO/2015/151924A1
Polyimides manufactured using an acid dianhydride represented by formula (1-1) for the acid component have a low linear expansion coefficient and high glass transition temperature and also have adequate transparency, low relative permitt...  
WO/2015/150241A1
The present invention provides a process for the production of furan, said process comprising the steps of: i) contacting furfural with a decarbonylation catalyst in a decarbonylation reactor to produce a gaseous decarbonylation reaction...  
WO/2015/150238A1
The present invention provides a process for the treatment of a liquid first furan stream comprising furan and carbon monoxide, said process comprising the steps of: i) contacting said first furan stream with a CO-lean first gaseous stre...  
WO/2015/149589A1
A method for preparing magnesium lithospermate B. The method is characterized in that: by adding a magnesium salt, magnesium lithospermate B is extracted or purified from a Salvia miltiorrhiza medicinal material or a Salvia miltiorrhiza ...  
WO/2015/150882A1
Process for preparing 1,1-disubstituted ethylene monomers The present invention relates to a process for preparing 1,1-disubstituted ethylene monomers having general formula (I) from a compound of general formula (II) and an active methy...  
WO/2015/148412A3
Provided herein are methods for producing cyclic and acyclic ketones from trimerization and dimerization of alkyl ketones, including for example methyl ketones. Such cyclic and acyclic ketones may be suitable for use as fuel and lubrican...  
WO/2015/143256A1
Compounds of Formula (I), including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:...  
WO/2015/140818A4
The present invention discloses novel bisphenol compounds of formula (I) which are useful for preparation of polymers with pendant furyl groups and a process for synthesis of the bisphenols and polymers therefrom.  
WO/2015/141504A1
The present invention is a radiation-sensitive resin composition containing a radiation-sensitive acid generator and a polymer having a structural unit containing an acid-dissociable group, the radiation-sensitive acid generator containi...  
WO/2015/140818A1
The present invention discloses novel bisphenol compounds of formula (I) which are useful for preparation of polymers with pendant furyl groups and a process for synthesis of the bisphenols and polymers therefrom.  
WO/2015/139827A1
The invention relates to a liquid crystal medium which contains at least one compound of the formula (I), in which R1 and R1* independently of each other represent an alkyl or alkyl group with 1 to 15 C atoms, wherein in said groups, one...  
WO/2015/137923A1
Nylon 12 may be produced by dimerization of 6-carbon furan compounds into 12-carbon dimers, and conversion of the dimers into nylon 12. The 6-carbon furan compounds may be produced from biomass. Ester-aldehyde dimers and amino-ester dime...  
WO/2015/137914A1
Nylon 7 may be produced from biomass derived 6-carbon hydroxymethyl furan compounds as the raw material. The hydroxymethyl furan compounds may be homologated to form an aldehyde that may be aminated to produce an amino carbonyl compound....  
WO/2015/133413A1
 Provided are: a method for producing furfural by bringing superheated steam into contact with biomass feedstock including hemicellulose obtained by bringing an acid catalyst and a wet agent comprising at least one of a surfactant, an ...  
WO/2015/133902A1
Psicose is converted into 5-hydroxymethylfurfural or an alkyl ether thereof in a process for the catalysed conversion of psicose, comprising the steps of: a. forming a feed comprising psicose and water or at least one alkanol or a mixtur...  
WO/2015/133540A1
The present invention relates to a method for producing furfural, said method having a reaction step in which a catalyst that includes sulfuric acid and a biomass feedstock that includes hemicellulose are supplied into a metal reactor, a...  
WO/2015/134314A1
This invention provides a process for producing biomass pellets and fermentable sugars from cellulosic biomass, comprising: extracting cellulosic biomass feedstock with steam and/or hot water to produce an extract liquor containing hemic...  
WO/2015/132396A1
Prodrugs (I) and (Ia) of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.  
WO/2015/131286A1
Disclosed are salts of a compound of formula 1, as shown below, where R1, R2, R3, R4, R5, R6 and R7 are as described herein. Also, disclosed is a process for the preparation of the salts of the compounds of formula 1, and intermediates u...  
WO/2015/127553A1
Disclosed is the use of a fruit kernel for producing biofuel or an intermediate in the production thereof. The fruit kernel is generally obtained from an avocado or mango and is used as a dry powder. Also disclosed are methods for produc...  
WO/2015/129896A1
In the present invention, a compound represented by a formula (1) (in the formula, R1, R2, Ar1, and Ar2 are as defined in the description) enables an organic electroluminescent element, for which low voltage driving is possible and which...  
WO/2015/129813A1
The present invention provides: a deuteration method that is both cost effective and has an excellent deuteration rate; a method for selectively replacing a leaving group of an aromatic compound with deuterium; and a deuteration catalyst...  
WO/2015/129832A1
 The present invention is a radiosensitive resin composition containing: a polymer having a structural unit that contains the group represented by formula (1); and a radiosensitive acid generator. In formula (1), R1 is a substituted or...  
WO/2015/126129A2
The present invention relates to a resveratrol multimer having a selective inhibitory activity for hepatitis C virus genome replication, and a use thereof, and more particularly, to a resveratrol multimer having a selective inhibitory ac...  
WO/2015/127137A1
The present invention provides compounds of formula I that bind to mitochondrial aldehyde dehydrogenase-2 (ALDH2), and methods of using said compounds to treat patients with i.a. cancer, Fanconi anemia and alcohol-related disorders. [For...  
WO/2015/125734A1
The present invention provides: a halohexahydrophthalic acid derivative that is a synthesis intermediate for an alicyclic or semialicyclic tetracarboxylic acid dianhydride, and that can be used as a raw material monomer for a polyimide w...  
WO/2015/122494A1
Provided is a novel compound having an excellent suppression action against arrhythmia including atrial fibrillation and being useful as a pharmaceutical product having a separated antiviral effect. A compound indicated by general formul...  
WO/2015/122522A1
The present invention addresses the issue of providing a highly pure gamma-butylolactone (GBL) that is capable of preventing the occurrence of unintended reactions during use, caused by high GBL acidity. This gamma-butylolactone composit...  
WO/2015/123389A1
A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.  
WO/2015/122187A1
A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the...  
WO/2015/117912A1
Compounds of formula (I), wherein (II) is a five-membered, aromatic ring system which may contain 2 or 3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulphur,and where each ring system may not contain more than ...  
WO/2015/115507A1
Provided is a compound represented by formula (I) [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof. This compound has an excellent TRPA1 antagonistic activity, which makes it possible t...  
WO/2015/115805A1
The present invention relates to a novel 2-phenylbenzofuran derivative or a pharmaceutically acceptable salt thereof, to a production method for same and to a pharmaceutical composition for preventing or treating an inflammatory disease ...  
WO/2015/115589A1
The present invention provides a halogen atom-substituted polymerizable compound having improved solubility in solvents and liquid crystals and able to be used in a liquid crystal aligning agent. The present invention provides a polymeri...  
WO/2015/113903A1
The invention relates to a method for producing 1-indanoles and 1-indanamines by palladium-catalyzed arylation and to the use thereof as intermediate products for the synthesis of fine chemicals and of agrochemical active substances.  
WO/2015/115613A1
The present invention provides: a good balanced resist which has high sensitivity without deteriorating basic physical properties of a chemically amplified resist such as resolution and line edge roughness (LER); and a compound for resis...  
WO/2015/111086A1
The present invention discloses one pot process for the conversion of hemicellulose into C5 sugars using ionic liquids in water media.  
WO/2015/110502A1
A composition comprising a polymer, or an oligomer, comprising cross-linking moiety, which moiety comprises a carbon-carbon triple bond; and a molecule comprising a carbon-carbon triple bond, wherein the thermal curing behavior of said m...  
WO/2015/113060A3
The present invention relates generally to processes for converting fructose-containing feedstocks to a product comprising 5-(hydroxymethyl)furfural (HMF) and water in the presence of water, solvent and an acid catalyst. In some embodime...  
WO/2015/111078A1
The present invention relates to an improved process for the preparation of 2,5-dimethylfuran and furfuryl alcohol over ruthenium supported catalysts. Further, the present invention disclosed a process for the selective hydrogenolysis of...  
WO/2015/113060A2
The present invention relates generally to processes for converting fructose-containing feedstocks to a product comprising 5-(hydroxymethyl)furfural (HMF) and water in the presence of water, solvent and an acid catalyst. In some embodime...  
WO/2015/108136A1
The present invention provides: a novel α-substituted glycinamide derivative or a pharmacologically acceptable salt thereof; a pharmaceutical composition containing the compound or the pharmacologically acceptable salt; and a use of the...  
WO/2015/109210A1
The disclosed subject matter provides N-hydroxymethanesulfonamide compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed...  
WO/2015/107541A1
The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use ...  

Matches 201 - 250 out of 29,475